The research theme conducted by the University of Tsukuba and supported by Celaid Therapeutics has been selected by the Japan Agency for Medical Research and Development (AMED) as a "Bridging Research Program (preF)" for FY2022.
＜Details of the AMED Adoption＞
Announcement: "Bridging Research Program (preF)" in FY2022
Supporting Organization: University of Tsukuba
Title of R&D Project: Establishment of cord blood transplantation for acute leukemia using novel hematopoietic stem cell expansion technology
Principal Investigator ：Professor Satoshi Yamazaki, University of Tsukuba